ATE88642T1 - Zusammensetzung und verfahren zur anwendung von in liposomen eingeschlossenen verbindungen in der neutroneneinfangtherapie von tumoren. - Google Patents

Zusammensetzung und verfahren zur anwendung von in liposomen eingeschlossenen verbindungen in der neutroneneinfangtherapie von tumoren.

Info

Publication number
ATE88642T1
ATE88642T1 AT89900703T AT89900703T ATE88642T1 AT E88642 T1 ATE88642 T1 AT E88642T1 AT 89900703 T AT89900703 T AT 89900703T AT 89900703 T AT89900703 T AT 89900703T AT E88642 T1 ATE88642 T1 AT E88642T1
Authority
AT
Austria
Prior art keywords
compounds
tumors
capture therapy
neutron
entracled
Prior art date
Application number
AT89900703T
Other languages
English (en)
Inventor
Gary Fujii
Paul Gardner Schmidt
Ronald Carl Gamble
Original Assignee
Vestar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vestar Inc filed Critical Vestar Inc
Application granted granted Critical
Publication of ATE88642T1 publication Critical patent/ATE88642T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89900703T 1987-11-04 1988-11-03 Zusammensetzung und verfahren zur anwendung von in liposomen eingeschlossenen verbindungen in der neutroneneinfangtherapie von tumoren. ATE88642T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11676487A 1987-11-04 1987-11-04
EP89900703A EP0386146B1 (de) 1987-11-04 1988-11-03 Zusammensetzung und verfahren zur anwendung von in liposomen eingeschlossenen verbindungen in der neutroneneinfangtherapie von tumoren
PCT/US1988/003820 WO1989004176A1 (en) 1987-11-04 1988-11-03 Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy

Publications (1)

Publication Number Publication Date
ATE88642T1 true ATE88642T1 (de) 1993-05-15

Family

ID=22369060

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89900703T ATE88642T1 (de) 1987-11-04 1988-11-03 Zusammensetzung und verfahren zur anwendung von in liposomen eingeschlossenen verbindungen in der neutroneneinfangtherapie von tumoren.

Country Status (8)

Country Link
EP (1) EP0386146B1 (de)
JP (1) JP2710847B2 (de)
KR (1) KR970009893B1 (de)
AT (1) ATE88642T1 (de)
AU (1) AU2820689A (de)
CA (1) CA1314209C (de)
DE (1) DE3880691T2 (de)
WO (1) WO1989004176A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648532A (en) * 1993-06-03 1997-07-15 The Regents Of The University Of California Compositions for boron neutron capture therapy and methods thereof
NO312708B1 (no) * 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioaktive liposomer til terapi
AU2003298738A1 (en) * 2002-11-26 2004-06-18 Su-Ming Chiang Liposomal formulations
WO2011006510A1 (en) 2009-07-17 2011-01-20 Technical University Of Denmark Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines
JP5947807B2 (ja) 2010-12-14 2016-07-06 テクニカル ユニバーシティ オブ デンマークＴｅｃｈｎｉｃａｌ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｄｅｎｍａｒｋ ナノ粒子組成物への放射性核種の封入
JP2025527735A (ja) * 2022-08-23 2025-08-22 サンノゼ ステート ユニバーシティ リサーチ ファウンデーション ホウ素化ナノスケール基材及びその使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992513A (en) * 1975-01-07 1976-11-16 Atomic Energy Of Canada Limited Labelled phospholipid material colloidially dispersed and sized to localize at preselected organs
US4516535A (en) 1982-06-22 1985-05-14 Nuclear Medicine, Inc. Methods for neutron-capture tumor therapy
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
US4674480A (en) * 1984-05-25 1987-06-23 Lemelson Jerome H Drug compositions and methods of applying same

Also Published As

Publication number Publication date
DE3880691D1 (de) 1993-06-03
DE3880691T2 (de) 1993-08-12
CA1314209C (en) 1993-03-09
EP0386146A1 (de) 1990-09-12
EP0386146A4 (en) 1990-10-24
WO1989004176A1 (en) 1989-05-18
EP0386146B1 (de) 1993-04-28
JPH03500888A (ja) 1991-02-28
KR970009893B1 (en) 1997-06-19
JP2710847B2 (ja) 1998-02-10
AU2820689A (en) 1989-06-01
KR890701134A (ko) 1989-12-19

Similar Documents

Publication Publication Date Title
NO996312L (no) Noeytron-dreven elementtransmuter
DE69941457D1 (de) Umwandelbare radiotherapievorrichtung und herstellungsverfahren
DE69133325D1 (de) Verwendung von 5,10,15,20-tetrakis(r-carboxyphenyl)porphin zum nachweis und zur behandlung von lungenkrebs
MARTIN et al. Induction of DNA Double‐Strand Breaks by 157Gd Neutron Capture
SE7404824L (sv) Sett och anordning for metning av koncentrationer av en komponent, ex. vis. jern, i en materialmengd.
ATE88642T1 (de) Zusammensetzung und verfahren zur anwendung von in liposomen eingeschlossenen verbindungen in der neutroneneinfangtherapie von tumoren.
RU93003328A (ru) Способ трансмутации изотопов
Arrhenius et al. Distribution of Radioactivity in Pelagic Clays 1
Mays et al. Progress in the beagle studies at the University of Utah
EP0752709A1 (de) Verfahren zur Erzeugung von Actinium-225
GB1365405A (en) Radionuclide generator and method for producing same
Meyer et al. High-spin three-quasiparticle states of Nb 93 populated in the beta decay of 21 2+ Mo m 93
Forssten et al. On positive parity levels of high angular momentum in 69, 71, 73ge
Berg et al. Transition rates in 161Dy
Lawrence Artificial radio-activity and neutron rays in biology and medicine
GB816412A (en) Improved silica glass and process for its manufacture
Gentry Cosmological implications of extinct radioactivity from pleochroic halos
Romani et al. Mitochondrial resistance to massive irradiation in vivo: IV. Suppression and recovery in rate of amino acid incorporation into mitochondrial protein
Maciejewski et al. Two sides of radon-a radioactive and healing component of water and air
Smith et al. Helium II Film Transport Rates over Various Surfaces
GB1240767A (en) Track registration process
Bonitz Evidence for a 130 ns isomeric state in 198Au
Hollnagel et al. Dosimetric quantities in the ICRU sphere for neutron irradiation with energies between thermal and 20 MeV
Roessler Occupational radiation exposure in Florida phosphate mining
Carss et al. Beta-Decay of Isomeric Cd 113

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time